Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Repertoire of driver events in coding and non-coding regions identified by whole-genome sequencing of myeloid neoplasms

Blood (2025) 146 (Supplement 1): 1450.

https://doi.org/10.1182/blood-2025-1450

Published: 2025

Journal Articles

Six versus eight doses of rituximab in combination with six cycles of CHOP chemotherapy in patients with previously untreated diffuse large b-cell lymphoma

Yoshimasa Kamoda, Futoshi Iioka, Masako Hirao, Hiromitsu Iizuka, Michiko Kida, Hitoshi Ohno, Takashi Akasaka, Kensuke Usuki, Motoshi Ichikawa

Blood (2025) 146 (Supplement 1): 2708.

https://doi.org/10.1182/blood-2025-2708

Published: 2025

Journal Articles

Platelet Count over Time Is Not Associated with Incidence of Thrombosis in Patients with Essential Thrombocythemia

Yoshimasa Kamoda, Ryo Yamashita, Masako Hirao, Hiromitsu Iizuka, Michiko Kida, Kensuke Usuki, Motoshi Ichikawa

Blood (2024) 144 (Supplement 1): 6663.

https://doi.org/10.1182/blood-2024-199541

Published: 2024

Journal Articles

Improved Survival with Venetoclax in Patients with Acute Myeloid Leukemia: A Retrospective Single-Center Cohort Study

Yoshimasa Kamoda, Masako Hirao, Hiromitsu Iizuka, Michiko Kida, Kensuke Usuki, Motoshi Ichikawa

Blood (2023) 142 (Supplement 1): 5936.

https://doi.org/10.1182/blood-2023-173795

Published: 2023

Journal Articles

Outcomes and Prognostic Scoring System for Elderly Patients with Acute Myeloid Leukemia

Fumi Nakamura, Sachiko Seo, Honoka Arai, Yuka Nakamura, Tomoyuki Handa, Wataru Takahashi, Shiho Furuichi, Fusako Nagasawa, Jiro Tadokoro, Shigeharu Tsurumi, Yuko Nakamura, Ko Sasaki, Motoshi Ichikawa, Kinuko Mitani

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-139350

Published: 2020

Journal Articles

ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study

Hitoshi Hanamoto, Yasuyoshi Morita, Motoshi Ichikawa, Yasuhito Nannya, MD PhD, Hirohiko Shibayama, MD PhD, Yoshinobu Maeda, MD, Tomoko Hata, Toshihiro Miyamoto, MD PhD, Hiroshi Kawabata, MD PhD, Kazuto Takeuchi, Hiroko Tanaka, Junji Kishimoto, Satoru Miyano, PhD, Itaru Matsumura, MDPhD, Seishi Ogawa, MD PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD, Kinuko Mitani

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-134483

Published: 2020

Journal Articles

Prospective Comparison of Azacitidine Treatment between 7-Days and 5-Days Schedules for Patients with Higher-Risk Myelodysplastic Syndromes; Results of Japan Adult Leukemia Study Group MDS212 Trial

Blood (2019) 134 (Supplement_1): 845.

https://doi.org/10.1182/blood-2019-122802

Published: 2019

Journal Articles

Contribution of MIR9 on Disease Progression of Chronic Myelogenous Leukemia

Ko Sasaki, MD PhD, Fusako Nagasawa, MD, PhD, Kenichi Yoshida, MD PhD, June Takeda, MD, Yuichi Shiraishi, PhD, Kenichi Chiba, B.A., Hiroko Tanaka, B.A., Ai Okada, Satoru Miyano, PhD, Motoshi Ichikawa, MD, PhD, Seishi Ogawa, MD PhD, Kinuko Mitani, MD, PhD

Blood (2017) 130 (Supplement 1): 4972.

https://doi.org/10.1182/blood.V130.Suppl_1.4972.4972

Published: 2017

Journal Articles

Somatic mosaicism in chronic myeloid leukemia in remission

Kinuko Mitani, Yasunobu Nagata, Ko Sasaki, Kenichi Yoshida, Kenichi Chiba, Hiroko Tanaka, Yuichi Shiraishi, Satoru Miyano, Hideki Makishima, Yukitsugu Nakamura, Yuka Nakamura, Motoshi Ichikawa, Seishi Ogawa

Blood (2016) 128 (24): 2863–2866.

https://doi.org/10.1182/blood-2016-06-723494

Published: 2016

Includes: Supplemental data

Journal Articles

The Genetic Landscape Of FPD/AML Revealed CDC25C Mutation As a Driver That Promotes Malignant Transformation

Akihide Yoshimi, MD, PhD, Takashi Toya, MD, Masahiro Nakagawa, MD, PhD, Masahito Kawazu, MD, PhD, Yasuhito Nannya, MD, PhD, Motoshi Ichikawa, MD, PhD, Shunya Arai, MD, PhD, Hironori Harada, MD, PhD, Kensuke Usuki, MD, PhD, Yasuhide Hayashi, MD, PhD, Etsuro Ito, MD, PhD, Keita Kirito, MD, PhD, Hideaki Nakajima, MD, PhD, Hiroyuki Mano, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2013) 122 (21): 739.

https://doi.org/10.1182/blood.V122.21.739.739

Published: 2013

Journal Articles

The Serial Profile of Vitamins and Mineral Microelements During the Acute Phase of Hematopoietic Stem Cell Transplantation.

Yasuhito Nannya, MD, PhD, Akihito Shinohara, M.D., Ph.D., Motoshi Ichikawa, M.D., Ph.D., Mineo Kurokawa, M.D.

Blood (2012) 120 (21): 3033.

https://doi.org/10.1182/blood.V120.21.3033.3033

Published: 2012

Journal Articles

AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors

Masahiro Nakagawa, Munetake Shimabe, Naoko Watanabe-Okochi, Shunya Arai, Akihide Yoshimi, Akihito Shinohara, Nahoko Nishimoto, Keisuke Kataoka, Tomohiko Sato, Keiki Kumano, Yasuhito Nannya, Motoshi Ichikawa, Yoichi Imai, Mineo Kurokawa

Blood (2011) 118 (25): 6626–6637.

https://doi.org/10.1182/blood-2010-12-326710

Published: 2011

Includes: Supplemental data

Journal Articles

The Increase of Peripheral Blood Monocytes After Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Chronic Graft-Versus-Host Disease and Late Mortality,

Takashi Toya, Dr., Sachiko Seo, Dr., Ryo Nasu, Dr., Motoshi Ichikawa, Mineo Kurokawa, MD

Blood (2011) 118 (21): 4064.

https://doi.org/10.1182/blood.V118.21.4064.4064

Published: 2011

Journal Articles

BAALC Regulates Hematopoietic Stem Cells Through P53 and Promotes Leukemia with Impaired P53 Function

Sumimasa Nagai, Keiki Kumano, Akihito Shinohara, Masahiro Nakagawa, Motoshi Ichikawa, Mineo Kurokawa

Blood (2011) 118 (21): 48.

https://doi.org/10.1182/blood.V118.21.48.48

Published: 2011

Journal Articles

Clinical Usefulness of Procalcitonin in Hematopoietic Stem Cell Transplantation

Junji Koya, Yasuhito Nannya, MD, Motoshi Ichikawa, Mineo Kurokawa, MD

Blood (2011) 118 (21): 4560.

https://doi.org/10.1182/blood.V118.21.4560.4560

Published: 2011

Journal Articles

Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19 ARF

Nahoko Nishimoto, Shunya Arai, Motoshi Ichikawa, Masahiro Nakagawa, Susumu Goyama, Keiki Kumano, Tsuyoshi Takahashi, Yasuhiko Kamikubo, Yoichi Imai, Mineo Kurokawa

Blood (2011) 118 (9): 2541–2550.

https://doi.org/10.1182/blood-2010-10-315440

Published: 2011

Journal Articles

Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells

Shunya Arai, Akihide Yoshimi, Munetake Shimabe, Motoshi Ichikawa, Masahiro Nakagawa, Yoichi Imai, Susumu Goyama, Mineo Kurokawa

Blood (2011) 117 (23): 6304–6314.

https://doi.org/10.1182/blood-2009-07-234310

Published: 2011

Includes: Supplemental data

Journal Articles

A Critical Role of Reactive Oxygen Species In the Generation of Megakaryocyte-Erythrocyte Progenitor Cells.

Akihito Shinohara, Yoichi Imai, Masahiro Nakagawa, Tsuyoshi Takahashi, MD, PhD, Motoshi Ichikawa, Mineo Kurokawa

Blood (2010) 116 (21): 1605.

https://doi.org/10.1182/blood.V116.21.1605.1605

Published: 2010

Journal Articles

AML1/Runx1 Is a Cytoplasmic Attenuator of NF-Kb Signaling: Implication in Pathogenesis and Targeted Therapy of AML1-Related Leukemia.

Masahiro Nakagawa, Munetake Shimabe, Nahoko Nishimoto, MD, Naoko Watanabe-Okochi, Motoshi Ichikawa, Yasuhito Nannya, Yoichi Imai, Mineo Kurokawa

Blood (2009) 114 (22): 1962.

https://doi.org/10.1182/blood.V114.22.1962.1962

Published: 2009

Journal Articles

Pbx-1 Is a Direct Target of Evi-1 in Hematopoietic Stem/Progenitors and Leukemic Cells.

Munetake Shimabe, Susumu Goyama, MD, PhD, Motoshi Ichikawa, MD, PhD, Yoichi Imai, MD, PhD, Tsuyoshi Takahashi, MD, PhD, Akira Hangaishi, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2008) 112 (11): 1192.

https://doi.org/10.1182/blood.V112.11.1192.1192

Published: 2008

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Repertoire of driver events in coding and non-coding regions identified by whole-genome sequencing of myeloid neoplasms

Six versus eight doses of rituximab in combination with six cycles of CHOP chemotherapy in patients with previously untreated diffuse large b-cell lymphoma

Platelet Count over Time Is Not Associated with Incidence of Thrombosis in Patients with Essential Thrombocythemia

Improved Survival with Venetoclax in Patients with Acute Myeloid Leukemia: A Retrospective Single-Center Cohort Study

Outcomes and Prognostic Scoring System for Elderly Patients with Acute Myeloid Leukemia

ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study

Prospective Comparison of Azacitidine Treatment between 7-Days and 5-Days Schedules for Patients with Higher-Risk Myelodysplastic Syndromes; Results of Japan Adult Leukemia Study Group MDS212 Trial

Contribution of MIR9 on Disease Progression of Chronic Myelogenous Leukemia

Somatic mosaicism in chronic myeloid leukemia in remission

The Genetic Landscape Of FPD/AML Revealed CDC25C Mutation As a Driver That Promotes Malignant Transformation

The Serial Profile of Vitamins and Mineral Microelements During the Acute Phase of Hematopoietic Stem Cell Transplantation.

AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors

The Increase of Peripheral Blood Monocytes After Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Chronic Graft-Versus-Host Disease and Late Mortality,

BAALC Regulates Hematopoietic Stem Cells Through P53 and Promotes Leukemia with Impaired P53 Function

Clinical Usefulness of Procalcitonin in Hematopoietic Stem Cell Transplantation

Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19 ARF

Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells

A Critical Role of Reactive Oxygen Species In the Generation of Megakaryocyte-Erythrocyte Progenitor Cells.

AML1/Runx1 Is a Cytoplasmic Attenuator of NF-Kb Signaling: Implication in Pathogenesis and Targeted Therapy of AML1-Related Leukemia.

Pbx-1 Is a Direct Target of Evi-1 in Hematopoietic Stem/Progenitors and Leukemic Cells.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only